Records containing: SARS-CoV-2
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-04-05Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care. Double-blind, Randomized, Comparative Study
-
CLINICAL_TRIALS study record update · 2022-04-04A Phase 2/3 Randomized, Multicenter, Double-Blind, Placebo Controlled, Dose-Response Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 Vaccine in Adults
-
CLINICAL_TRIALS study record update · 2022-04-04An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Hospitalized Patients at Onset of Clinical Progression of COVID-19
-
CLINICAL_TRIALS study record update · 2022-04-04Phase 1, Randomized, Double-Blind, Dose-Escalation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Nanoparticle Carrier-Formulated Self-Replicating Replicon RNA (repRNA) Vaccine in Healthy Adults
-
CLINICAL_TRIALS study record update · 2022-04-01A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults, to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-03-22PEP Flute-selfcare to Prevent Respiratory Deterioration and Hospitalization Among COVID-19 Patients: a Randomized Trial
-
CLINICAL_TRIALS study record update · 2022-03-17Influences of Allergic Rhinitis and Allergen Immunotherapy on Human Antibody Responses to SARS-CoV-2 Vaccination
-
CLINICAL_TRIALS study record update · 2022-03-15A Two-part, Two-cohort, Double-blind, Randomized, Placebo-controlled, Multicenter Phase 1/2 Study to Evaluate the Safety, Tolerability and Efficacy of REJUVEINIX (RJX) in Patients With COVID-19
-
CLINICAL_TRIALS study record update · 2022-03-10A Phase 2/3, Randomized, Open-label, Parallel Group, 3-arm, Multicenter Study Investigating the Efficacy and Safety of Intravenous Administrations of Emapalumab, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and Anakinra, an Interleukin-1(IL-1) Receptor Antagonist, Versus Standard of Care, in Reducing Hyper-inflammation and Respiratory Distress in Patients With SARS-CoV-2 Infection.
-
CLINICAL_TRIALS study record update · 2022-02-18A Phase 2 Trial Evaluating Sargramostim in Patients With COVID-19 Associated Acute Hypoxemia
-
CLINICAL_TRIALS study record update · 2022-02-15Personalized Health Education Against the Health Damage of COVID-19 Epidemic in Hungary (PROACTIVE-19)
-
CLINICAL_TRIALS study record update · 2022-02-03The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19
-
CLINICAL_TRIALS study record update · 2022-01-31Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students
-
CLINICAL_TRIALS study record update · 2022-01-21Evaluation of the COVIDSeq Test in Saliva Specimens From Illumina Personnel
-
CLINICAL_TRIALS study record update · 2022-01-21Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From an Asymptomatic Population
-
CLINICAL_TRIALS study record update · 2021-12-16Efficacy of Hydroxychloroquine for Post-exposure Prophylaxis (PEP) to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Adults Exposed to Coronavirus Disease (COVID-19): a Blinded, Randomized Study
-
CLINICAL_TRIALS study record update · 2021-12-09Bovine Lactoferrin for the Prevention of COVID-19 Infection in Physicians and Nurses in Hospitals in Lima, Peru: a Double Blinded Randomized Clinical Trial (LF-COVID)
-
CLINICAL_TRIALS study record update · 2021-12-09Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines: Adenovirus-vectored Vaccine Versus mRNA Vaccine
-
CLINICAL_TRIALS study record update · 2021-12-03A Randomised, Double-blind, Placebo Controlled Study of Eicosapentaenoic Acid (EPA-FFA) Gastro-resistant Capsules to Treat Hospitalised Subjects With Confirmed SARS-CoV-2
-
CLINICAL_TRIALS study record update · 2021-12-03A Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Virological Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sirolimus Adjuvant Therapy in Patients With Coronavirus Disease (COVID-19)
-
CLINICAL_TRIALS study record update · 2021-11-24The Dynamics of the Immune Response to Infection by SARS Coronavirus 2
-
CLINICAL_TRIALS study record update · 2021-11-18A Global, Multi-center, Randomized, Double-Blind, Placebo-controlled, Phase III Clinical Study to Evaluate the Protective Efficacy, Safety and Immunogenicity of SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine in Population Aged 18 Years and Older
-
CLINICAL_TRIALS study record update · 2021-11-05NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons
-
CLINICAL_TRIALS study record update · 2021-10-28Hydroxychloroquine to Prevent SARS-CoV-2 Infection Among Healthcare Workers: Randomized Controlled, Open-label, Phase 3 Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-10-27Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients: the CORDAGES Study